We’re thrilled to share that our oral presentation was chosen as noteworthy and one of eight Presidents’ Select Abstracts at this year’s @American Diabetes Association Scientific Sessions. Our co-founder and CEO Harith Rajagopalan shared exciting new preclinical data from our investigational #genetherapy program REJUVA®. For more information: https://lnkd.in/eTVrZWEf *Rejuva is in preclinical development and has yet to be assessed by regulatory agencies #ADASciSessions #ADA2024
Congratulations!
President, Cardiology Sales, Chair Close The Gap, (Health Equity) Boston Scientific | MBA, Sales & Commercial Excellence/Public Board Member/Private Board Member
3moGreat opportunity! Game changer for weight maintenance!